Search - tctmd.com

Displaying 221 - 240 of 334

Sort: Relevancy | Date

News Daily News

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Caitlin E. Cox

February 26, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Presenter: Roxana Mehran

December 01, 2013

Presentation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Presenter: Martin T. Rothman

December 01, 2013

News Conference News TCT 2013

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

November 04, 2013

Presentation TCT 2013

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Presenter: Dmitriy Feldman

October 28, 2013

News Daily News

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Caitlin E. Cox

October 23, 2013

Presentation

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

Presenter: Christoph Varenhorst

October 18, 2013

News Daily News

无并发症DES患者长期使用阿司匹林与双联疗法效果相同

Jason Kahn

October 11, 2013

News Daily News

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

Jason Kahn

October 11, 2013

News Daily News

La Aspirina a Largo Plazo es tan Eficaz como la Terapia Doble en Pacientes SLF Sin Complicaciones

Jason Kahn

October 11, 2013

Presentation

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

Presenter: C.W. Lee

October 10, 2013

News Daily News

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Caitlin E. Cox

October 04, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

Presentation

Clinical Outcomes of PCI Performed Without Preprocedural Aspirin

Presenter: M. Kenaan

October 02, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

Presentation ESC 2013

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

Presenter: 32040|Roxana Mehran

September 01, 2013

News Daily News

控制良好的华法林不会降低三联疗法出血风险

August 30, 2013

News Daily News

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

August 30, 2013

News Daily News

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

August 30, 2013

Advertisement

Apixaban Cost-Effective Compared with Warfarin or Aspirin

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Triple Antiplatelet Therapy with Cilostazol Increases Tachycardia, Arrhythmias

Aspirin and ADP Antagonists Pre- and Post-coronary Stent Implantation

Longer DAPT Duration Reduces Adverse Events After PCI for In-Stent Restenosis

Duration of Dual Antiplatelet Treatment with Clopidogrel and Aspirin in Patients with ACS

无并发症DES患者长期使用阿司匹林与双联疗法效果相同

Long-term Aspirin as Effective as Dual Therapy in Uncomplicated DES Patients

La Aspirina a Largo Plazo es tan Eficaz como la Terapia Doble en Pacientes SLF Sin Complicaciones

Optimal Duration Of Dual Antiplatelet Therapy After DES Implantation

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Clinical Outcomes of PCI Performed Without Preprocedural Aspirin

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI):Results from the Real-World PARIS Registry

控制良好的华法林不会降低三联疗法出血风险

El Riesgo Hemorrágico de la Terapia Triple No lo Atenúa la Warfarina Bien Controlada

Bleeding Risk of Triple Therapy Not Attenuated by Well-Controlled Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content